Literature DB >> 6281019

The influence of reducing agents on the composition of 99Tc-complexes: implications for 99mTc-radiopharmaceutical preparation.

J Baldas, J Bonnyman, P M Pojer, G A Williams.   

Abstract

The use of formamidine sulphinic acid as a reducing agent in the presence of technetium-99-pertechnetate and diethyldithiocarbamate ligand has been shown to yield a complex containing a Tc = CO bond. The carbon monoxide present in this complex originates from the reducing agent itself. Evidence is presented which suggests that this carbonyl complex is present in the 99mTc-diethyldithiocarbamate preparation obtained by the use of formamidine sulphinic acid as the reducing agent. Use of hydrazine as a reducing agent yields a complex containing a Tc = N bond. It is apparent that when reducing agents such as hydrazine or formamidine sulphinic acid are used in the preparation of 99mTc-radiopharmaceuticals, the possibility of the formation of complexes structurally different to those obtained by the use of stannous chloride must be considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281019     DOI: 10.1007/bf00443930

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  PREPARATION OF TECHNETIUM (TC99M)-LABELED SERUM ALBUMIN (HUMAN).

Authors:  H S STERN; I ZOLLE; J G MCAFEE
Journal:  Int J Appl Radiat Isot       Date:  1965-04

2.  Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex: implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn (II) reduction of pertechnetate.

Authors:  E Deutsch; R C Elder; B A Lange; M J Vaal; D G Lay
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

Review 3.  Radiopharmaceuticals labelled with technetium.

Authors:  W C Eckelman; S M Levenson
Journal:  Int J Appl Radiat Isot       Date:  1977 Jan-Feb

4.  Technetium 99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects.

Authors:  R J Baker; J C Bellen; P M Ronai
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

5.  The chemistry of technetium labeling of radiopharmaceuticals by electrolysis.

Authors:  J Steigman; W C Eckelman; G Meinken; H S Isaacs; P Richards
Journal:  J Nucl Med       Date:  1974-02       Impact factor: 10.057

6.  Technetium-99m-labelled N,N-diethyldithiocarbamate--a non-polar complex with slow hepatic clearance.

Authors:  P M Pojer; J Baldas
Journal:  Int J Nucl Med Biol       Date:  1981

7.  The use of formamidine sulphinic acid in the preparation of 99mTc-labelled radiopharmaceuticals--a cautionary note.

Authors:  J Baldas; P M Pojer
Journal:  Int J Nucl Med Biol       Date:  1981

8.  Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.

Authors:  A R Fritzberg; D M Lyster; D H Dolphin
Journal:  J Nucl Med       Date:  1977-06       Impact factor: 10.057

9.  The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA.

Authors:  W C Eckelman; G Meinken; P Richards
Journal:  J Nucl Med       Date:  1972-08       Impact factor: 10.057

  9 in total
  3 in total

1.  Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.

Authors:  Merve Karpuz; Evren Atlihan-Gundogdu; E Selin Demir; Zeynep Senyigit
Journal:  AAPS PharmSciTech       Date:  2021-02-02       Impact factor: 3.246

Review 2.  Ciprofloxacin: from infection therapy to molecular imaging.

Authors:  Syed Ali Raza Naqvi; Samina Roohi; Anam Iqbal; Tauqir A Sherazi; Ameer Fawad Zahoor; Muhammad Imran
Journal:  Mol Biol Rep       Date:  2018-07-04       Impact factor: 2.316

3.  Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies.

Authors:  Emre Ozgenc; Merve Karpuz; Ege Arzuk; Marta Gonzalez-Alvarez; Marival Bermejo Sanz; Evren Gundogdu; Isabel Gonzalez-Alvarez
Journal:  ACS Omega       Date:  2022-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.